|Podcasts|April 29, 2021
Episode 81: Cancer Research Amid COVID
Author(s)Elaine Quilici
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.
Advertisement
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, talks about the challenges and silver linings of continuing cancer research during the pandemic.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Director of NIH Infectious Disease Institute Steps Down
4
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
5